Brown Rudnick, LLP, on Behalf of Lupin Pharmaceuticals, INC.

Law Firm

Based in DC

🤖

AI Overview

With $40K in lobbying spend across 7 quarterly filings, Brown Rudnick, LLP, on Behalf of Lupin Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.

$40K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$40K
2019$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues

  • H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
  • H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.